EXHIBIT 10.9
EXECUTION VERSION
AMENDMENT NO. 2
AMENDMENT NO. 2 dated as of November 10, 2016 (this “Incremental Amendment”), to the CREDIT AGREEMENT dated as of August 18, 2015 (as amended by that certain Amendment No. 1, dated as of May 31, 2016, and as further amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”), among JAGUAR HOLDING COMPANY II, a Delaware corporation (the “Parent Borrower”), PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC, a Delaware limited liability company (the “Subsidiary Borrower”), JAGUAR HOLDING COMPANY I, a Delaware corporation (“Holdings”), each lender from time to time party thereto (collectively, the “Lenders” and, individually, a “Lender”), and CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as Administrative Agent, Collateral Agent and an L/C Issuer. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Credit Agreement.
A. The Borrowers have notified the Incremental Term Loan Lender and the Incremental Arrangers (each as defined below) that they intend to pay a cash dividend to the direct or indirect equityholders of Parent Borrower in an aggregate amount of $525,000,000 (the “Special Dividend”).
B. Pursuant to Section 2.14 of the Credit Agreement, the Borrowers have requested an increase in the aggregate principal amount of the existing Term Loan Tranche outstanding under the Credit Agreement on the terms and conditions set forth herein and in the Credit Agreement, and the Borrowers have appointed JPMorgan Chase Bank, N.A., Barclays Bank PLC, UBS Securities LLC, Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc. and Credit Suisse Securities (USA) LLC as the Incremental Arrangers and Joint Bookrunners in connection therewith (collectively, the “Incremental Arrangers”).
C. Accordingly, in consideration of the mutual agreements herein contained and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties hereto agree to this Incremental Amendment.
SECTION 1.Incremental Amendment.
a. On and as of the Incremental Amendment Effective Date (as defined below), the party hereto providing the Incremental Term Loan Commitment (as defined below) as indicated on Annex I hereto (the “Incremental Term Loan Lender”) hereby provides the Incremental Term Loan Commitment set forth opposite its name on Annex I attached hereto (it being agreed that the Incremental Term Loans (as defined below) shall be funded at 99.75% of the principal amount thereof, and notwithstanding said discount all calculations hereunder and under the Credit Agreement with respect to the Incremental Term Loans, including the accrual of interest and the repayment or prepayment of principal, shall be based on 100% of the stated principal amount thereof) on the terms and subject to the conditions provided for herein (the “Incremental Term Loan Commitment” and the loans to be made in respect thereof subject to the terms and conditions provided for herein, the “Incremental Term Loans”). The Incremental Term Loans shall be provided in accordance with, and be subject to all of the terms and conditions set forth in, the Credit Agreement (including, without limitation, Section 2.14 thereof).